ClinicalTrials HQ

ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer

ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer

Active, not recruiting · NCT04662580 · Registry updated 2026-09-28
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate CancerGenital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, metastatic prostate carcinoma, neoplasm, prostate cancer, prostate disorderActive, not recruitingPhase 12026-09-28NCT04662580

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Janssen Research & Development, LLC188

12 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Carolina Urologic Research CenterMyrtle BeachUnited States55
GU Research NetworkOmahaUnited States3
Indiana University Melvin and Bren Simon Cancer CenterIndianapolisUnited States1
UC San Diego Moores Cancer CenterLa JollaUnited States199
UCSF Medical Center at Mission BaySan FranciscoUnited States1
University Hospitals Cleveland Medical CenterClevelandUnited States234
University of California, Los Angeles School of MedicineLos AngelesUnited States1
University of Michigan Comprehensive Cancer CenterAnn ArborUnited States1
University of WashingtonSeattleUnited States3
Washington University St. Louis School Medicine Siteman Cancer CenterSt LouisUnited States1
Weill Cornell Medical CollegeNew YorkUnited States1
Winship Cancer Institute of Emory UniversityAtlantaUnited States45